Our essential guide to the top legal outfits south of the Sahara advising on private equity
Early repayment of its bailout and solid M&A interest from foreign investors have brought optimism to Portugal’s lawyers.
Technology M&A is leading the way in Israel as foreign companies clamour to invest, but will a regulator’s U-turn put the brakes on growth?
While deal numbers were up last year, their value rocketed – and this time it’s not the US firms taking the lion’s share.
Loss of PE star Oliver Felsenstein must surely force firm’s hand over lockstep reform.
Contemplating collaboration: charities and NGOs working together download subscription
Five top tips for those thinking about collaborating.
White-collar crime in Serbia subscription
Time runs out for bearer shares subscription
Serious incident reporting and charity trustees subscription
Clifford Chance and King & Wood Mallesons (KWM) have picked up top roles advising National Australia Bank (NAB) on its $5.5bn capital raising for a possible demerger from Clydesdale Bank
Dechert, Sullivan & Cromwell and White & Case have all taken roles in the $12.7bn pharmaceutical deal between US pharmacy chains CVS Health and Omnicare.
Clifford Chance and Sullivan & Cromwell have taken lead roles on advising Barclays in relation to its $2.3bn (£1.4bn) foreign exchange manipulation penalty fine – the largest fine of the six global banks to settle with global financial regulators on Wednesday (20 May).
Linklaters’ ambition to be part of the “global elite” has taken a significant step in the right direction as the firm succeeded in winning the role of principal adviser to Unilever from Slaughter and May.
Mothercare’s general counsel Tim Ashby is leaving the company in September for FTSE 100 real estate investment trust Land Securities.
Travers Thorp Alberga (TTA) has strengthened its corporate and funds team with the hire of former Herbert Smith partner and FourWinds Capital Management general counsel Louise Freestone.